Efficacy of Autologous Adipose Derived Stromal Vascular Fraction for Musculoskeletal Conditions
NCT ID: NCT06000670
Last Updated: 2025-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
300 participants
INTERVENTIONAL
2026-12-30
2028-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Knee Osteoarthritis (KOA) by Injection of Autologous Adipose-derived Vascular Matrix Components (SVF) Into Joint Cavity
NCT06109220
SVF Therapy for Human Knee Osteoarthritis
NCT05019378
Safety and Efficacy of Autologous SVF Cells in Treating Patients With Osteoarthritis
NCT02846675
Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Faction (SVF) for Treatment of Osteoarthritis of the Knee
NCT03940950
Treatment of Osteoarthritis With the Stromal Vascular Fraction of Abdominal Adipose Tissue - a Pilot Study
NCT02697682
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
knee osteoarhritis
patients with grade 2 and above chondromlacia as well as all grades of osteoarhtritis
stromal vascular fraction injection in the osteoarthritic knee
stromal vascular fraction harvested from mid abdominal wall under sedation and seperated from fat using mechanical centrifugation .injection of 5 cc of the SVF in the affected knee.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stromal vascular fraction injection in the osteoarthritic knee
stromal vascular fraction harvested from mid abdominal wall under sedation and seperated from fat using mechanical centrifugation .injection of 5 cc of the SVF in the affected knee.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* knee chondromalacia grade 2 and above
Exclusion Criteria
* pregnant women
* Mental disease
* severe cardio vascular disease
* severe coagulation disorders
* infected tissues
* patients on other experimental studies within 3 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dubai Health Authority
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amer Mansour
consultant orthopedic surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
DHA DHA
Role: STUDY_DIRECTOR
dubai health autority
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
cell surgical network
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DHA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.